Cite

HARVARD Citation

    Bar-Gil Shitrit, A. et al. (n.d.). P635 Risankizumab - real world Israeli data in severe refractory IBD patients. Journal of Crohn's and colitis. pp. i767-i768. [Online]. 
  
Back to record